Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria
Phase of Trial: Phase IV
Latest Information Update: 25 Jun 2018
Price : $35 *
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 15 Jun 2018 Status changed from active, no longer recruiting to completed.
- 09 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.